Jilin Aodong Pharmaceutical Group Co (SZSE:000623) LT-Debt-to-Total-Asset : 0.00 (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Jilin Aodong Pharmaceutical Group Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Jilin Aodong Pharmaceutical Group Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.00.

Jilin Aodong Pharmaceutical Group Co's long-term debt to total assets ratio stayed the same from Mar. 2023 (0.00) to Mar. 2024 (0.00).

Jilin Aodong Pharmaceutical Group Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Jilin Aodong Pharmaceutical Group Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jilin Aodong Pharmaceutical Group Co LT-Debt-to-Total-Asset Chart

Jilin Aodong Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.08

0.07

Jilin Aodong Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Jilin Aodong Pharmaceutical Group Co LT-Debt-to-Total-Asset Calculation

Jilin Aodong Pharmaceutical Group Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	21.494	/	32266.141
	=	0.00

Jilin Aodong Pharmaceutical Group Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	19.15	/	32560.327
	=	0.00

Jilin Aodong Pharmaceutical Group Co (SZSE:000623) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Jilin Aodong Pharmaceutical Group Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Jilin Aodong Pharmaceutical Group Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jilin Aodong Pharmaceutical Group Co Ltd (SZSE:000623) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

No. 2158, Jidong Street, Dunhua, CHN, 133700

Website

http://www.jlaod.com

Jilin Aodong Pharmaceutical Group Co Ltd is engaged in manufacturing of pharmaceuticals. Its products include Anshen Bunao Liquid, Antelope Cough Syrup, Yangxue Yin Oral Liquid, Xinnao Shutong Capsule, Calf Spleen Extract Injection, Xuefu Zhuyu Oral Liquid, and others.

Executives

Guo Shu Qin	Directors, executives
Wang Zhen Yu	Directors, Directors, and Executives
Zhao Da Long	Director
Yang Kai	Directors, executives
Li Xiu Lin	Director
Zhang Shu Yuan	Directors, executives
Chen Yong Feng	Supervisors
Zhang Ming Jing	Supervisors
Li An Ning	Supervisors
Lin Xiao Lin	Executives
Ying Gang	Director
Guo Li	Supervisors
Xu Dong Lin	Supervisors
Zhu Yan	Directors, executives
Li Li Ping	Supervisors

Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Headlines

No Headlines